NSCLC, STAGE III
Clinical trials for NSCLC, STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC, STAGE III trials appear
Sign up with your email to follow new studies for NSCLC, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study is testing a combination of two immunotherapy drugs plus standard chemotherapy given before surgery for patients with stage 2 or 3 non-small cell lung cancer. The goal is to see if this three-drug approach can shrink tumors more effectively before they are surgically r…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for vulnerable lung cancer patients excluded from other trials
Disease control Recruiting nowThis study is testing a new targeted cancer drug called repotrectinib specifically in frail or elderly patients with advanced lung cancer driven by a specific gene change (ROS1). The goal is to see if the drug is effective and tolerable for this vulnerable group, who are often le…
Matched conditions: NSCLC, STAGE III
Phase: PHASE2 • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Could a prostate cancer treatment help fight lung cancer?
Disease control Recruiting nowThis study is testing whether combining a hormone therapy drug (leuprorelin) with an immune-boosting drug (sintilimab) can better control advanced lung cancer. Researchers want to see if the hormone therapy rejuvenates the immune system to make the immunotherapy more effective. T…
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: Jinzhou Medical University • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Can exercise help lung cancer patients during treatment?
Symptom relief Recruiting nowThis pilot study is testing whether a personalized, home-based exercise program is practical and safe for people with stage II or III lung cancer who are undergoing combined treatments like chemotherapy and surgery. The program is delivered through telehealth and starts before tr…
Matched conditions: NSCLC, STAGE III
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC